In his weekly clinical update, Dr. Griffin highlights measles outbreaks throughout the continental US, reviews recent statistics on the circulation of respiratory syncytial virus, influenza and SARS-CoV-2 before discussing if vaccination protected children from the development of long COVID or cardiovascular diseases associated with virus infection, revised guidelines SARS-CoV-2 treatment and how to treat respiratory viral infections, continues to dispel the myth of viral rebound, when to use steroids and the benefits of convalescent plasma, how COVID-19 effects the autonomic nervous system, and if nirmatrelvir-ritonavir protects against adverse cardiovascular effects following SARS-CoV-2 infection.
Click arrow to play
Download TWiV 1096 (30 MB .mp3, 41 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Measles everywhere (CDC) 2:00
- Respiratory disease surveillance (CDC)
- RSV surveillance (CDC) 5:23
- RSV national trend (CDC)
- Estimating niresevimab effectiveness for infants (MMWR) 5:45
- More than 100 children died of influenza (NBS News) 11:19
- Influenza/flu surveillance (CDC)
- Influenza/flu map (CDC)
- COVID-19 hospital admissions (CDC)
- COVID-19 national trend (CDC) 14:56
- COVID-19 wastewater testing (biobot)
- Variant tracker (CDC)
- Variant hospital admissions (CDC)
- Did the vaccine protect children against Long COVID (Pediatrics) 15:47
- Did COVID-19 vaccination impact cardiovascular diseases? (Nat Comm) 20:14
- CDC Quarantine guidelines (CDC)
- NIH COVID-19 treatment guidelines (NIH) 25:23
- Molnupiravir safety and efficacy (JMV)
- Convalescent plasma recommendation for immunocompromised (IDSociety)
- Updated respiratory infection guidelines (CDC) 25:40
- What do when your heathcare provider is infected with SARS-CoV-2 (CDC) 34:18
- Managing healthcare staffing shortages (CDC)
- Steroids,dexamethasone at the right time (OFID)
- Anticoagulation guidelines (hematology.org)
- Long COVID trial for autonomic nervous system dysfunction (NIH) 28:00
- Nirmatrelvir-ritonavir impact on myocardial injury and long-term cardiovascular outcomes in COVID-19 hospitalized patients (Cardiovascular Drugs and Therapy) 29:23
- Contribute to our ASTMH fundraiser at PWB 31:50
- Letters read on TWiV 1096 32:05
- Dr. Griffin’s COVID treatment summary (pdf)
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
Leave a Reply